NT-112: Autologous, engineered T Cells targeting KRAS G12D: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase breakdown

Phase 1 1

Condition	Trials
Colorectal Carcinoma	1
Colorectal cancer	1
Endometrial Cancer	1
KRAS G12D	1
Lung cancer	1
Non-small Cell Lung Cancer	1
Pancreatic Ductal Adenocarcinoma	1
Pancreatic cancer	1
Solid Tumor, Adult	1

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
NCT06218914 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations

1 recruiting trial across 9 conditions.

No. For the full record, search ClinicalTrials.gov.